Shareholders Equity: The sum of preferred and common equity items.
Basilea Pharmaceutica AG (BPMUF) had Shareholders Equity of $92.01M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$250.93M |
|
$17.49M |
|
$37.80M |
|
$292.79M |
|
$51.75M |
|
$108.95M |
|
$133.48M |
|
$200.79M |
|
$92.01M |
|
$91.58M |
|
|
Shareholders Equity |
$92.01M |
-- |
|
| Cash Flow Statement Financials | |
$84.47M |
|
$-1.15M |
|
$-14.95M |
|
$73.06M |
|
$141.49M |
|
$68.42M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|